Navigation Links
Grifols Honors Texas Plasma Donors During Plasma Protein Therapies Month
Date:8/11/2009

AUSTIN, Texas, Aug. 11 /PRNewswire/ -- Today, Grifols SA (Grifols), a global healthcare company based in Barcelona, Spain, begins a month long celebration of Texas plasma donors in recognition of the state resolution designating August 2009 as "Plasma Protein Therapies Month." Grifols owns and operates 17 plasma donor facilities throughout the state of Texas and more than 80 across the United States. Grifols' national testing laboratory, headquartered in Austin, Texas, performs more than 1 million tests each month to assure the health and safety of Grifols' donors and the medicines produced from their plasma donations.

"We applaud the Texas House of Representatives for designating August as Plasma Protein Therapies Month and thank the thousands of Texas plasma donors who make treatment possible for many patients who depend on plasma medicines," said company spokesman Christopher Healey. "Too often, people with rare diseases go unnoticed and undertreated; this will go a long way to raise public awareness of these medicines and the conditions they treat."

Plasma donated at Grifols facilities is used to produce therapies such as intravenous immune globulin (IVIG) to treat primary immune deficiency, blood clotting factors to treat hemophilia and other bleeding disorders, and albumin, which is used for shock, trauma, and burns. Patients with a primary immune deficiency suffer with a severely compromised immune system that makes them susceptible to debilitating and potentially life-threatening infections and diseases. Individuals with hemophilia and related bleeding disorders are lacking the essential blood proteins necessary for their blood to properly clot. For these conditions and others, regular and life-long treatment with plasma therapies is often the only treatment option.

For more information about donating plasma and its life-saving properties please visit www.donatingplasma.org.

About Grifols

Grifols SA (Grifols) is a global healthcare company founded in 1940 in Barcelona, Spain. Today Grifols products and services are provided in more than 90 countries around the world. Grifols specializes in the production of plasma therapies to treat a variety of rare and often life-threatening diseases and conditions. Grifols operates 80 plasma donor centers throughout the US and has manufacturing and testing facilities located in Barcelona, Spain, Austin, Texas, and Los Angeles, California.


'/>"/>
SOURCE Grifols, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America
2. Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona
3. Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries
4. Grifols Biomat USA Opens New Plasma Donor Center in Lincoln
5. Thirteen Courage Center Youth Athletes Take Top Honors in National Sports Competition
6. National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010
7. AMERIGROUP Foundation Honors Warehouse of Hope Founder Craig Parson as a Healthy Hero
8. THA Honors 12 Legislators for Contributions to Health Care
9. School of Health Management Honors 162 Graduating Students
10. Award Honors Chicago Cancer Survivor Who Gives Back
11. California Association of Physician Groups Honors Heritage Provider Networks With Elite Status of Care Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ., the ... has been recognized as one of the best small businesses for new dads by ... of nine small businesses providing progressive benefits to new parents on the organization’s ...
(Date:5/27/2016)... ... , ... With over 60 percent of acute stroke survivors being left unable ... aid in the rehabilitation process has steadily increased. Ekso Bionics had been working to ... to stroke. , Ekso Bionics has now received clearance from the U.S. Food and ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities ... within the industry, from leading advocates, associations and industry leaders such as Bioness. ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Beleza Medspa ... body fat composition regulations. This is the first time that Coolsculpting is being ... at least every six months to ensure they meet the prescribed body-fat standard, measured ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
(Date:5/24/2016)... 24, 2016 Cirujanos holandeses han ... a los médicos a compartir sus mejores prácticas por ... mundial. Profesionales médicos de Europa, África, Asia ... a la aplicación, que combina la transmisión en vivo ... seguro. Educación   "Imagine un médico ...
Breaking Medicine Technology: